PALATINE, Ill., March 2, 2009 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) today reported 2008 net income of $14.5 million or $0.29 per diluted share compared to a net loss of $4.3 million, or $0.11 per share loss for 2007. For the quarter ended December 31, 2008, we had a net loss of $3.0 million, or $0.07 per share loss compared to net income of $9.5 million, or $0.20 per diluted share for the same quarter in 2007. As of February 27, 2009, we had cash, cash equivalents and short-term investments of approximately $37.6 million with no term indebtedness.
